Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19

Frontiers in Pharmacology

Niraj Kumar Jha¹  Charu Sharma²  M. F. Nagoor Meeran³  Shreesh Ojha³  Chandragouda R. Patil⁴  Sameer N. Goyal⁵ 

[1] Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India;Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates;Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates;Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India;Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, India;

关键词: COVID-19;    infection;    inflammation;    immunomodulators;    serratiopeptidase;    drug repurposing;   

DOI  :  10.3389/fphar.2021.603997

来源: DOAJ

【 授权许可】

Unknown